To further characterize the IMEC subsets within the tumor, we evaluated the interaction between MHC‐II receptors expressed on TECs and MHC‐II ligands expressed on CD4+ T cells (Figure 6A–C; Figure S1G). Here, CD4 is linked to neoplasm.